key: cord-0791169-op6x6w90 authors: Perez-Nieto, O. R.; Escarraman-Martinez, D.; Guerrero-Gutierrez, M. A.; Zamarron-Lopez, E. I.; Mancilla-Galindo, J.; Kammar-Garcia, A.; Martinez-Camacho, M. A.; Deloya-Tomas, E.; Sanchez-Diaz, J. S.; Macias-Garcia, L. A.; Soriano-Orozco, R.; Cruz-Sanchez, G.; Salmeron-Gonzalez, J. D.; Toledo-Rivera, M. A.; Mata-Maqueda, I.; Morgado-Villasenor, L. A.; Martinez-Mazariegos, J. J.; Flores Ramirez, R.; Medina-Estrada, J. L.; Namendys-Silva, S. A.; Group, APRONOX title: Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study date: 2021-01-31 journal: nan DOI: 10.1101/2021.01.27.21250631 sha: c5949ceed7c052b7363310acf3fd52454cfaba36 doc_id: 791169 cord_uid: op6x6w90 Purpose: The awake prone position (PP) strategy for patients with acute respiratory distress syndrome (ARDS) is a safe, simple, and cost-effective technique used to improve hypoxemia. We aimed to evaluate the relationship between awake PP (AP) and endotracheal intubation in patients with coronavirus disease (COVID-19). Methods: In this retrospective, multicentre observational study conducted between 1 May and 12 June 2020 in 27 hospitals in Mexico and Ecuador, non-intubated patients with COVID-19 managed with AP or awake supine positioning (AS) were included to evaluate intubation and mortality risk in AP patients through logistic regression models; multivariable adjustment, propensity score analyses, and E-values were calculated to limit confounding. A CART model with cross-validation was also built. This study was registered at https://clinicaltrials.gov/ct2/show/NCT04407468 Results: 827 non-intubated patients with COVID-19 in the AP (n=505) and AS (n=322) groups were included for analysis. Less patients in the AP group required endotracheal intubation (23.6% vs 40.4%) or died (20% vs 37.9%). AP was a protective factor for intubation even after multivariable adjustment (OR=0.39, 95%CI:0.28-0.56, p<0.0001, E-value=2.01), which prevailed after propensity score analysis (OR=0.32, 95%CI:0.21-0.49, p<0.0001, E-value=2.21), and mortality (adjusted OR=0.38, 95%CI:0.25-0.57, p<0.0001, E-value=1.98). The main variables associated with PP failure in AP patients were age, lower SpO2/FiO2, and management with a non-rebreather mask. In the CART model, only two variables were used: SpO2/FiO2 (F 97.7, p<0.001) and PP (X2 50.5, p<0.001), with an overall percentage of 75.2%. Conclusion: PP in awake hospitalised patients with COVID-19 is associated with a lower risk of intubation and mortality. The prone position (PP) in awake, non-intubated patients with acute hypoxemic respiratory failure results in improved oxygenation, as demonstrated by an increase in arterial partial pressure of oxygen (PaO 2 ), peripheral arterial oxygen saturation (SpO 2 ), and PaO 2 /inspired oxygen fraction (PaO 2 /FiO 2 ), without deleterious effects on the level of partial arterial pressure of carbon dioxide (PaCO 2 ), pH, respiratory rate (RR), or haemodynamics (1, 2) . PP combined with non-invasive ventilation (NIV) or high-flow nasal cannula (HFNC) in patients with moderate to severe acute respiratory distress syndrome (ARDS) has been shown to be safe and effective and may prevent intubation (3, 4) . The pathophysiological mechanism by which PP is useful for ARDS is by increasing functional residual capacity, reducing dead space, reducing intrapulmonary shunts, increasing ventilation in areas dependent of gravity, and relieving the weight that the heart exerts over the lungs (5) . The coronavirus disease (COVID-19) pandemic has unleashed a high global demand for respiratory support, a reason why PP in awake non-intubated patients has become popular and clinical interest has rapidly increased. An early strategy combining PP together with NIV or HFNC has been reported to be associated with reduced intubation and mortality and improved oxygenation (6) (7) (8) . One further advantage of PP without intubation is that it allows patients to interact with their family during hospitalisation, thereby favouring humanisation of healthcare (9) . Nonetheless, few observational studies have included control groups (i.e. awake supine patients managed with NIV or HFNC) and have had conflicting findings. While Ferando et al. (10) and Padrão et al. (11) found no differences in intubation risk between prone and supine patients, Jagan et al. (12) found a reduction in intubation risk for PP patients. Thus, the utility of awake PP remains to be further elucidated in larger observational or randomised studies. In this multicentre retrospective observational study, we sought to explore the relationship between awake PP and the need for orotracheal intubation, and to develop a model to predict this outcome. The secondary objective was to compare and explore the association between awake PP and mortality risk in the APRONOX study. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 31, 2021. ; https://doi.org/10.1101/2021.01.27.21250631 doi: medRxiv preprint A multicentre retrospective cohort study was conducted with patients diagnosed with COVID-19 admitted to the emergency department in 27 hospitals in Mexico and Ecuador (Appendix 2). The study was approved by the Health Services Research Committee of the State of Querétaro (registration number 1178/SESEQ-HGSJR/08-05-20) and all other participating centres. This study was prospectively registered in ClinicalTrials.gov (NCT04407468); STROBE recommendations were followed during the reporting of this study. In each participating hospital centre, data collection was carried out by medical specialists in emergency medicine, respiratory medicine, anaesthesiology, and intensive care medicine, who collected information from patients' medical records. A separate group of physicians were appointed to review the data obtained and check for plausibility. In cases of doubt physicians in charge at each hospital centre were contacted. Patients were deidentified by assigning them a code. All patients admitted to the emergency department during the period between 1 May and 12 June 2020 who met the following criteria were ultimately included in the study: Data System (CO-RADS) score > 3 (Appendix 3) (13), together with two or more of the following symptoms: eye pain, cough, fever, dyspnoea, headache, arthralgia, or odynophagia. Patients who self-discharged or who were referred to another hospital centre prior to outcome ascertainment, and those with incomplete clinical records, were excluded from the study. Data recorded were demographic (age, sex) and clinical variables including comorbidities (diabetes, systemic arterial hypertension, obesity, heart disease, lung disease, cancer, liver disease, chronic kidney disease), pre-prone SpO 2 /FiO 2 ratio (14) , supplemental oxygen delivery device used, need for orotracheal intubation, and lethal outcome. FiO 2 was calculated based on the type of supplemental oxygen delivery device employed: low-flow nasal cannula, high-flow nasal cannula or non-rebreather mask (Appendix 4) (15). The decision to place patients in the prone position and perform orotracheal intubation was based on individualised medical criteria and was not priorly defined or standardised. The objective of this study was to explore the relationship between orotracheal intubation as the dependent variable and the prone position in awake patients diagnosed with SARS-CoV-2 as an independent variable. Due to the observational nature of the study and the fact it posed no risk to study participants, convenience sampling was employed with the goal of recruiting the largest number of participants to maximise statistical power. The clinical and demographic characteristics of the patients were examined for all patients and for those in the awake PP (AP) or awake supine position (AS) groups. Descriptive results for quantitative variables are presented as mean with standard deviation (SD), and frequencies with percentage (%) for qualitative variables. Asymmetry and kurtosis were calculated for quantitative variables. Quantitative comparisons were performed with the independent-samples t-test; qualitative comparisons were done with chi-squared or Fisher's exact test. Baseline and post-AP SpO 2 /FiO 2 ratios were compared with the dependent-samples t-test. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 31, 2021. ; https://doi.org/10.1101/2021.01.27.21250631 doi: medRxiv preprint To reduce the risk of bias due to unbalanced groups, propensity score analysis was performed through a logistic regression model adjusted for age, sex, the presence of 3 or more comorbidities and baseline SpO 2 /FiO 2 ratio. Patients were matched in a 1:1 ratio according to the nearest-neighbour matching algorithm; changes in density functions are shown in Appendix 5. All inferential analyses were performed for all patients in the original cohort and for the propensity score-matched cohorts. Distinct multivariable logistic regression analyses were performed to determine the risk of orotracheal intubation and mortality associated with AP. Variables included in the models were selected by the Enter method; adjustment variables were those which had a p value <0.1 in univariate analyses which have been reported to be associated with higher risk for adverse events (age, sex [men], diabetes, systemic arterial hypertension, obesity, heart disease, cancer, chronic kidney disease), pre-prone SpO 2 /FiO 2 ratio, and supplemental oxygen delivery device). A multivariable logistic regression model was subsequently created for AP patients to determine the risk of failure to pronation; the variables included in this model were selected with the Stepwise Forward method, including those with a p<0.1 in the final model. Odds ratios (OR) with their 95% confidence interval (95%CI) were calculated. The goodness of fit of the final model was evaluated with the Hosmer-Loemeshow statistic, and the discrimination of the model was determined by calculating the area under the curve (AUC). The risk of failure to AP according to age and baseline SpO 2 /FiO 2 ratio were graphed through the smoothing spline method. E-values for the lower bound of the confidence intervals were calculated to determine the value at which an unmeasured confounding factor could potentially alter the observed effect of AP on the outcomes and drive them to a non-significant value (16) . Regression analyses were verified through residual analysis. A classification and regression tree (CART) model were constructed with cross-validation, the QUEST (Quick, Unbiased, Efficient, Statistical Tree) growing method, and pruning control to prevent overfitting (reduce standard error). This methodology is based on developing hierarchical binary classification trees with sensitivity analysis based on the Gini index (17) . . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 31, 2021. ; https://doi.org/10.1101/2021.01.27.21250631 doi: medRxiv preprint A systematic review of studies of AP was conducted; the search strategy and inclusion criteria for studies are provided in Appendix 6. Results of eligible studies were summarised alongside the propensity score-matched cohort of APRONOX in a forest plot and the overall risk for intubation for patients in AP vs AS was calculated. Missing values were not imputed. A p-value <0.05 was used to define bilateral statistical significance. All analyses and graphs were created with the SPSS software v.21, R software v.3.4.2, and RevMan 5.3. Out of 932 patients identified across all 27 hospital centres, 827 patients were ultimately included for analysis ( Figure 1 ). Descriptive results for all patients are provided in Table 1 . The results of univariable logistic regression models for orotracheal intubation risk are provided in Table 3 , for both the unmatched and matched cohorts. The main risk factors identified were age, diabetes, arterial hypertension, obesity, heart disease, cancer, a baseline SpO 2 /FiO 2 <100 or between 100 and 199, and management with a non-rebreather mask. Ventilation in AP was a protective factor for orotracheal intubation even after multivariable adjustment Table 4 for confounding variables (Adjusted OR=0.39, 95%CI:0.28-0.56, p<0.0001, E-value=2.01), which prevailed after propensity score analysis (Adjusted OR=0.32, 95%CI:0.21-0.49, p<0.0001, E-. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 31, 2021. The CART model is shown in Figure 2 After the search of the literature, 54 records were obtained, of which only 3 studies were comparison-group studies including both AP and AS patients for which sufficient information was available to the overall risk for intubation, which are summarised alongside the APRONOX study in Figure 4 . In this multicentre observational study, we aimed to evaluate the association between awake prone positioning and orotracheal intubation, as well as predictors of failure to prone positioning and mortality in hospitalised patients with COVID-19. Even after multivariable adjustment and propensity score analyses, prone positioning in non-intubated patients was associated with lower intubation and mortality risk. We further developed a CART model to evaluate the relationship between AP and intubation. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 1 0 Patients in our cohort were younger (mean age 53.4 years) than those in other studies (56.0-65.8) (10-12); hospitalised patients with COVID-19 in Mexico have been reported to be young (18) . The prevalence of comorbidities in our study is similar to that reported in a populationbased sample of Mexican patients hospitalised with COVID-19, although diabetes was more common in our study (38.1% vs 29.2%), whereas obesity (14.4% vs 22.5%) and heart disease (2.1% vs 4.4%) were less frequent (18) . The overall intubation rate in the APRONOX cohort was higher (30.1%) than that reported for hospitalised patients with COVID-19 in Mexico City (20.2%) (18) ; however, limited access to beds with ventilators in Mexico has been reported (19) . Intubation rates for patients in the unmatched AP (23.6%) and AS (40.4%) cohorts fall within those reported in previous studies (10-58% and 27.7-49%, respectively) (10-12). Awake prone positioning in our study was associated with decreased intubation risk even after multivariable adjustment in both the unmatched and propensity-score matched cohorts, with an E-value of 2.01 and 2.21, respectively, which reflects that in order to drive this association to be non-significant, an unmeasured risk factor should have a lower-limit confidence interval that at least doubles the risk of the outcome between both groups. Out of all comorbidities, only diabetes and heart disease were associated with increased intubation risk after multivariable adjustment, although diabetes was no longer a risk factor after propensity score analysis. Baseline SpO 2 /FiO 2 was associated with reduced intubation risk. The mortality rate reported in our study was 19.8%, comparable to 23.4% (12) and 27% (10) in other studies. Regarding variables associated to failure to awake prone positioning, age, SpO 2 /FiO 2 , and the use of a non-rebreather mask were the main variables associated. The distribution of risk for quantitative values of age show that the risk of failure is higher with increasing ages, whereas higher baseline SpO 2 /FiO 2 have the lowest failure risks. The decision rules obtained from the CART model were as follows: 1.-Regardless of sex, patients with an initial SpO 2 /FiO 2 ratio <177.6 have a 43.5% chance of being intubated, while patients with an initial SpO 2 /FiO 2 ratio >177.6 have only a 15.9% chance of being intubated. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 1 1 2.-Among patients with an initial SpO 2 /FiO 2 ratio <177.6, when prone positioning is not used, the likelihood of intubation increases to 66.4%, while PP reduces this figure to 30.8%. Thus, when the SpO 2 /FiO 2 ratio upon admission is under 177.6, risk of intubation is increased. This is comparable to findings by Thompson et al., who found that the mean difference in the intubation rate between patients with SpO 2 at 95% or greater and patients with SpO 2 less than 95% one hour after initiation of PP was 46% (8) . PP has been presented as one the most cost-effective strategies to treat patients with COVID-19. In countries with limited oxygen delivery devices, and a shortage of ventilators, AP has been routinely used to avoid intubating patients with COVID-19 (20). Nonetheless, conflicting evidence from observational studies for AP exists. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 31, 2021. ; https://doi.org/10.1101/2021.01.27.21250631 doi: medRxiv preprint Regarding modality of ventilation, the use of a non-rebreather mask was associated with greater risk of intubation and failure to prone positioning, whereas other modalities of ventilation were not. There is documented evidence of the correlation between the oxygen saturation/fraction of inspired oxygen (SaO 2 /FiO 2 ) ratio and the partial pressure of oxygen/fraction of inspired oxygen (PaO 2 /FiO 2 ) ratio, with the advantage that the SaO 2 /FiO 2 ratio only relies on a pulse oximeter, with no need to perform a blood gas test, thereby highlighting the value of validated costeffective strategies (14) . Unsupervised machine learning algorithms are being increasingly used in medicine as techniques to support the development of models to improve clinical decisions. Such models have been used in attempts to achieve early, adequate predictions of ARDS with the goal of improving diagnosis, treatment and monitoring, using clinical and demographic data (26), or by adding genomic information to evaluate response to treatment (27) or to identify different phenotypes of a disease (28). Our model contributes valuable information that may be used to decide whether to initiate PP in a patient or not. Although no statistically significant association was found between types of O 2 delivery device, it was shown that PP determines whether intubation is needed or not, regardless of the type of device used. These prediction techniques could serve as a guide for healthcare workers in resource-strained settings to guide decision making (29). Our study has the following limitations: 1) O 2 delivery devices were not standardised to a unique device; 2) the number of hours of PP varied between hospitals and patients; and 3) no precise criteria were established to consider intubation in patients requiring IMV. Nonetheless, this reflects how PP is used in real-world settings. The strengths of our research include: 1) this is the largest study evaluating AP to date; 2) the large number of hospitals included; and 3) the fact that various O 2 delivery devices were employed, showing that the benefits of PP are not necessarily unique to NIV or HFNC devices, which are costlier and not always available. PP in spontaneously breathing patients with acute hypoxemic respiratory insufficiency may be a justifiable treatment modality, given the improvements in oxygenation and its physiological benefits, but the decision to intubate is based on the clinician's best judgement and intubation . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 31, 2021. ; https://doi.org/10.1101/2021.01.27.21250631 doi: medRxiv preprint should not be delayed if under consideration. Close clinical evaluation of patients is key to avoid poor outcomes. Studies of PP in non-intubated patients are challenging and randomized controlled trials are warranted to fully elucidate their usefulness since this is an easy to administer, safe, and reproducible intervention (30). PP in awake hospitalised patients with COVID-19 is associated with a lower risk of intubation and mortality. The authors declare no conflicts of interest. Data availability: All data that support the findings of this study will be available from the corresponding author upon reasonable request. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 31, 2021. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 31, 2021. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 1 7 Available from: https://ispmbern.github.io/covid-19/living-review/ . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 31, 2021. ; https://doi.org/10.1101/2021.01.27.21250631 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 31, 2021. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 31, 2021. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 31, 2021. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 31, 2021. ; https://doi.org/10.1101/2021.01.27.21250631 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 31, 2021. ; https://doi.org/10.1101/2021.01.27.21250631 doi: medRxiv preprint Figure 3 . Risk of prone positioning failure according to age and baseline SpO 2 /FiO 2 95%CI: 95% confidence intervals; FiO2: Inspired oxygen fraction; SpO2: peripheral arterial oxygen saturation . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 31, 2021. ; https://doi.org/10.1101/2021.01.27.21250631 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 31, 2021. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 31, 2021. ; https://doi.org/10.1101/2021.01.27.21250631 doi: medRxiv preprint Intensive Care Unit. Hospital General San Juan del Rio, Querétaro, Mexico 2. Department of Anaesthesia. Hospital de Especialidades Centro Médico Nacional "LaRaza Department of Critical Care Medicine. Instituto Nacional de Cancerología Intensive Care Unit Intensive Care Unit. Hospital General de México Intensive Care Unit. Hospital de Alta Especialidad IMSS Intensive Care Unit. Hospital Vida Mejor ISSSTECH Tuxtla Gutiérrez, Chiapas, Mexico 17. Intensive Care Unit. Hospital de Especialidades "5 de Mayo Response to the prone position in spontaneously breathing patients with hypoxemic respiratory failure Prone positioning improves oxygenation in spontaneously breathing nonintubated patients with hypoxemic acute respiratory failure: A retrospective study Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study. Crit Care Prone positioning combined with high-flow nasal cannula in severe noninfectious ARDS. Crit Care Protocol for awake prone positioning in COVID-19 patients: to do it earlier, easier, and longer. Crit Care Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province. Ann Intensive Care Awake Prone Positioning in COVID-19 Hypoxemic Respiratory Failure: Exploratory Findings in a Single-center Retrospective Cohort Study The POSITIONED Study: Prone Positioning in Nonventilated Coronavirus Disease Patients-A Retrospective Analysis CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS George Institute for Global Health, Australian and New Zealand Intensive Care Society Clinical Trials Group. Oxygen therapy in nonintubated adult intensive care patients: a point prevalence study Web Site and R Package for Computing E-values. Epidemiology Aproximación a la metodología basada en árboles de decisión (CART) COVID-19 patients with increasing age experience differential time to initial medical care and severity of symptoms Hospital mortality in mechanically ventilated COVID-19 patients in Mexico OR 'SARS-CoV-2' OR 'SARS-CoV 2' OR 'SARS coronavirus 2') AND (prone) AND (awake).The following filters were applied for study design: case series, case-control study, cohort study, trial, other, or unclassified. Studies were chosen regardless of language, provided an abstract in English was available, and if the study included and clearly differentiated patients undergoing awake prone positioning from those in awake supine position, as well as intubation rates for both groups.